Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkad102
Abstract: Abstract Objectives To assess the effectiveness and tolerability of dolutegravir (DTG)/lamivudine (3TC) among treatment-naive and virologically suppressed treatment-experienced individuals in the multicentre cohort of the Spanish HIV/AIDS Research Network (CoRIS) during the years 2018–2021. Methods…
read more here.
Keywords:
hiv;
dolutegravir lamivudine;
tolerability dolutegravir;
effectiveness tolerability ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofad101
Abstract: Abstract Background We assessed the efficacy and safety of dolutegravir/lamivudine (DTG/3TC) in a US test-and-treat setting at a secondary 48-week time point of the multicenter, single-arm, phase IIIb STAT study. Methods Participants were eligible adults…
read more here.
Keywords:
dtg 3tc;
test treat;
dolutegravir lamivudine;
treat ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Research Journal of Pharmacy and Technology"
DOI: 10.52711/0974-360x.2021.00428
Abstract: A novel, economic, simple, precise and time-efficient reverse-phase high performance liquid chromatographic (RPHPLC) method has been established for the simultaneous assay determination of Dolutegravir, Lamivudine and Tenofovir Disoproxil fumarate in tablet formulation. This research paper…
read more here.
Keywords:
tenofovir disoproxil;
dolutegravir lamivudine;
disoproxil fumarate;
method ... See more keywords